期刊文献+

塞来昔布对宫颈癌细胞的化疗增敏作用 被引量:3

Effect of Celecoxib on Chemotherapy Sensitization for Cervical Cancer Cells
下载PDF
导出
摘要 目的探讨特异性环氧化酶-2(COX-2)抑制剂塞来昔布对顺铂诱导宫颈癌Hela细胞增殖与凋亡的作用及机制。方法采用四甲基偶氮唑蓝比色法(MTT),测定塞来昔布对顺铂诱导Hela细胞增殖活性的作用;应用流式细胞仪检测细胞凋亡率;Western blot检测Hela细胞中Bcl-2、Bax蛋白的表达情况。结果 5、10μmol/L的塞来昔布分别与顺铂联合应用,可增强顺铂对Hela细胞增殖抑制作用。塞来昔布(5μmol/L)能促进顺铂诱导Hela细胞的凋亡。塞来昔布作用于Hela细胞后,Bcl-2蛋白表达水平下调、Bax蛋白表达水平上调呈浓度依赖关系。结论塞来昔布能促进顺铂对Hela细胞增殖抑制和诱导凋亡作用,起化疗增敏作用,可能与其下调Bcl-2蛋白表达水平、上调Bax蛋白表达水平有关。 Objective To investigate the effect and its mechanism of celecoxib on cisplatin-induced proliferation and apoptosis in cervical cancer Hela cells.Methods The proliferation of celecoxib on cisplatin-induced cervical cancer Hela cells was examined by MTT assay.The apoptosis of Hela cells were tested by PI staining flow cytometry.The expression and their activity change of Bcl-2,Bax protein in Hela cells were investigated by Western blot.Results 5,10μmol/L concentrations of celecoxib combined with cisplatin significantly increased the cytotoxicity of cisplatin to Hela cells.Celecoxib(5μmol /L) significantly promoted cisplatin to induced Hela cells apoptosis.the expression levels of Bcl-2 protein were decreased and the expression level of Bax protein was increased in Hela cells treated with celecoxib in a concentration dependent manner(P〈0.05).Conclusion Celecoxib could enhance the effect of growth inhibtion and apoptosis induction of cisplatin on Hela cells.The effect of chemosensitization to cisplatin of celecoxib on Hela cells may be associated with downregulating the expression of Bcl-2 protein and upregulating the expression of Bax protein.
出处 《实用癌症杂志》 2011年第5期452-455,共4页 The Practical Journal of Cancer
关键词 宫颈癌 塞来昔布 凋亡 顺铂 化疗增敏 Cervical cancer Celecoxib Apoptosis Cisplatin Chemosensitization
  • 相关文献

参考文献13

  • 1Wendum D,Masliah J,Trugnan G,et al.Cyclooxygenase-2 and its role in colorectal cancer development[J].Virchows Arch,2004,445(4):327.
  • 2Khuri FR,Wu H,Lee JJ,et al.Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage Ⅰ non-small cell lung cancer[J].Clin Cancer Res,2001,7(4):861.
  • 3Uefuji k,Ichikura T,Mochizuki H.Expression of cyclooxygenase-2 in human gastric adenomas and adenocarcinomas[J].J Surg Oncol,2001,76(1):26.
  • 4France M,Drew PA,Dodd T,et al.Cyclo-oxygenase-2 expression in esophageal adenocarcinoma as a determinant of clinical outcome following esophagectomy[J].Dis Esophagus,2004,17(2):136.
  • 5Visscher DW,Pankratz VS,Santisteban M,et al.Association between cyclooxygenase-2 expression in atypical hyperplasin and risk of breast cancer[J].J Natl Cancer Inst,2008,100(6):421.
  • 6Fermandina G,Lauriola L,Distefano MG,et al.Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients[J].J Clin Oncol,2002,20(4):973.
  • 7许新华,胡国清,李道俊,薛峰,顾纪荣,鲁明骞.环氧合酶-2对鼻咽癌血管生成及预后的影响[J].中华放射肿瘤学杂志,2003,12(3):154-157. 被引量:16
  • 8易芳,许新华.塞来昔布在肿瘤防治中的研究进展[J].临床肿瘤学杂志,2007,12(4):316-318. 被引量:8
  • 9Shoji T,Takatori E,Murai M,et al.Results of neoadjuvant chemotherapy using tri-weekly CDDP/CPT211 for locally advanced cervical cancer[J].Gan To Kagaku Ryoho,2010,37(4):643.
  • 10刘天亮,吴云.多西紫杉醇联合顺铂治疗晚期乳腺癌21例分析[J].中国误诊学杂志,2008,8(3):707-707. 被引量:2

二级参考文献47

  • 1Zirmnermann KC, Sarbia M, Weber AA, et al. Cydooxy~2expression in human esophageal carcimm. Cancer Res, 1999,59: 198-204.
  • 2Tvajii M, Kawamo S, Tsuji S, et al. Cyelooxygenase regulatesangiogenesis induced by colon cancer cells. Cell, 1998,93:705-716.
  • 3EI-Assal ON, Yamanoi A, Soda Y, et al. Clinical significance ofmicrovessel density and vascular endothelial growth factor expression inhepatocellular carcin~,m and surrounding liver: possible involvement ofvasc~ar endothelial growth factor in the angiogenesis of cirrhotic liver.Hepatology, 1998, 27:1554-1562.
  • 4Cao Y, O' Reilly MS, Marshall B, et al. Expression of angiostatincDNA in a nmrine fibrosarconm ~ppresses primary tumor growth andproduce long-term dormancy of metastasis. J Cain Invest, 1998, 101 :1055.
  • 5Weidner N. Current pathologic methods for measuring intratmnoralmicrovessel density within breast carcinoma and other solid ~.Breast Cancer Res Treat, 1995,36:169-180.
  • 6Ryu HS, Chang KH, Yang HW, et al. High cyclooxygenase-2expression in stage IB cervical cancer with lymph node metastasis orparametrieal invasion. Gynecol Oncol, 2000,76:320-325.
  • 7Garcia-Rodriguez LA, Alvarez HC. Reduced risk of colorectal canceramong long-term users of aspirin and nonsteroidal antiinflammatorydrugs. Epidemiology, 2001,12:88-93.
  • 8Oshima M, Dinch~k JE, Kargman S, et al. Suppression of intestinalpolyposis in Apcb'716 knock out mice by inhibition of cydooxygenase-2(COX-2). Cell, 1996,87:803-809.
  • 9Oshima M, Murai N, Kargman S, et al. Chemoprevention of intestinalpolyposis in the Apc~'/16 mouse by rofecxib, aspecific cyclooxygenase-2inhibitor. Cancer Res, 2001,61 : 1733-1740.
  • 10l)ul~is RN, Shao J, T~ajii M, et al. GI deldy in cells overexpressingprostaglandin endoperoxide synthase-2. Cancer Res, 1996,56:733-737.

共引文献48

同被引文献63

  • 1金正均.合并用药中的相加[J].中国药理学报,1980,1:70-73.
  • 2王彦玲,马卫东,蒋常文,赵俊霞,周娜静,郑力芬,赵娟,闫蕴力.上调Sp1表达对小细胞肺癌耐药细胞的化疗增敏作用[J].细胞生物学杂志,2007,29(4):605-608. 被引量:2
  • 3孙建衡,蔡树模,高永良.妇科肿瘤学[M].北京:北京大学医学出版社,2011:2-10.
  • 4Akre K, Ekstrom AM, Signorello LB, et al. Aspirin and risk forgastric cancer: a population-based case-control study in Sweden[ J].Br J Cancer, 2001, 84(7) : 965 -968.
  • 5Zhang X,Chen ZG, Choe MS, et al. Tumor growth inhibition bysimultaneously blocking epidermal growth factor receptor and cycloox-ygenase-2 in a xenograft model [ J ]. Clin Cancer Res, 2005,11(17): 6261 -6269.
  • 6Tachimori A, Yamada N, Amano R, et al. Combination therapy ofS-l with selective cyclooxygenase-2 inhibitor for liver metastasis ofcolorectal carcinoma[ J]. Anticancer Res, 2008, 28 (2A) : 629 -638.
  • 7Choi S, Sano D, Cheung M, et al. Vandetanib inhibits growth ofadenoid cystic carcinoma in an orthotopic nude mouse model [ J ].Clin Cancer Res, 2008, 14(16) : 5081 -5089.
  • 8JooYE,Chung IJ, Park YK, et al. Expression of cyclooxygenase-2,p53 and Ki-67 in gastric cancer [ J ] . J Korean Med Sci, 2006, 21(5): 871 -876.
  • 9Kobayakawa M, Kojima Y. Tegafur/gimeracil/oteracil (S-l) ap-proved for the treatment of advanced gastric cancer in adults whengiven in combination with cisplatin: a review comparing it with otherfluoropyrimidine-based therapies [ J ]. Onco Targets Ther, 2011, 4:193 -201.
  • 10Wilgus TA, Breza TS Jr, Tober KL, et al. Treatment with 5-fluorou-racil and celecoxib displays synergistic regression of ultraviolet lightB-induced skin tumors [J]. J Invest Dermatol, 2004, 122(6) : 1488-1494.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部